Melanoma Molecular Map Project Launches Research-Use Computational Tool for Personalized Treatment | GenomeWeb

The Melanoma Molecular Map Project has launched an open-access computational tool, called the Targeted Therapy Analyzer, which allows researchers to match the molecular profile of a patient's tumor to a targeted melanoma drug.

The TTA, available here, allows users to implement "algorithms necessary to summarize the literature data and to match" the right drugs to patients based on the molecular features of their tumors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.